FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    2 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and etynodiol diacetate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 320 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely methscopolamine 2.5 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydroflumethiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely enalapril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 7.5 milligram and ibuprofen 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diphenhydramine 38 milligram and ibuprofen 200 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 50 microgram and etynodiol diacetate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely paracetamol 150 milligram and sodium salicylate 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 2.5 microgram and norethisterone acetate 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely paracetamol 650 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 5 milligram and ibuprofen 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and propranolol hydrochloride 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and lisinopril 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 50 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diprophylline 200 milligram and guaifenesin 100 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 10 milligram and ibuprofen 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely enalapril 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely enalapril 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ephedrine sulfate 25 milligram and guaifenesin 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ibuprofen 200 milligram and pseudoephedrine 30 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and losartan potassium 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.1 gram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely pseudoephedrine hydrochloride 120 milligram and terfenadine 60 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely paracetamol 250 milligram and salicylamide 600 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely pseudoephedrine hydrochloride 60 milligram and triprolidine hydrochloride 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely paracetamol 325 milligram and tramadol 37.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lovastatin 20 milligram and nicotinic acid 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dutasteride 500 microgram and tamsulosin hydrochloride 400 microgram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ephedrine hydrochloride 12.5 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lovastatin 20 milligram and nicotinic acid 1 gram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ephedrine sulfate 15 milligram and theophylline 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 500 milligram and repaglinide 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 100 milligram and ritonavir 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 30 milligram and methyldopa 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 556 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norethisterone 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely indapamide 1.25 milligram and perindopril erbumine 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely tegafur 100 milligram and uracil 224 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lamivudine 30 milligram and zidovudine 60 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely sulfamethoxazole 100 milligram and trimethoprim 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ephedrine hydrochloride 25 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lamivudine 150 milligram and stavudine 30 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 60 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely methenamine mandelate 300 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely trandolapril 2 milligram and verapamil hydrochloride 180 milligram/1 each prolonged-release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 650 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely domiphen bromide 500 microgram and lidocaine hydrochloride 5 milligram/1 each conventional release oromucosal lozenge Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely guanethidine monosulfate 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely methionine 250 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glipizide 2.5 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and valsartan 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glipizide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier

    Start Previous Page 5 of 35 Next End

    This concept is not in any reference sets

    Back to Start